The clinical implications of rsk1-3 in human breast cancer

MLA

Zhao, H., et al. The Clinical Implications of Rsk1-3 in Human Breast Cancer. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..3929f8d63cc75893997fb1a0cb6c9828&authtype=sso&custid=ns315887. Accessed 12 Feb. 2025.

APA

Zhao, H., Martin, T. A., Davies, E. L., Ruge, F., Yu, H., Zhang, Y., Teng, X., & Wen G. Jiang. (n.d.). The clinical implications of rsk1-3 in human breast cancer.

Chicago

Zhao, H., T. A. Martin, E. L. Davies, F. Ruge, H. Yu, Y. Zhang, X. Teng, and Wen G. Jiang. 2025. “The Clinical Implications of Rsk1-3 in Human Breast Cancer.” Accessed February 12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..3929f8d63cc75893997fb1a0cb6c9828&authtype=sso&custid=ns315887.